Life Sciences Products & Reviews

Sino Biological provides a wide range of influenza virus research reagents and technical services, supporting vaccine safety and immunogenicity assessment and vaccine protective efficacy evaluation.

Cell-free protein synthesis (CFPS) systems allow rapid protein production in vitro without the use of living cells. Sino Biological provides high-quality proteins with short lead times, accelerating your research and development process.

Accelerate process development with Raman-based real-time monitoring of critical cell culture parameters, without the cost and complexities of “black box” empirical calibration modeling.

MAVEN gives you automated, don’t-even-sweat-it, on-line monitoring of glucose and lactate concentrations in cell culture and fermentation processes. Get real-time process insights and dynamic control of substrate feeding without the loss of bioreactor volume.

MX908 is a multi-mission handheld, portable mass spectrometer utilized by elite responders conducting chemical, explosive, priority drug and HazMat operations around the world. MX908 detects compounds at trace levels with a high level of sensitivity and unparalleled selectivity, giving you actionable intelligence that other technologies can’t.

Sino Biological has successfully developed a series of GMP-grade cytokines using the GMP-grade quality management system, which utilizes superior quality management and release testing criteria.

Sino Biological offers a wide range of products and services to provide customers with complete multispecific antibody development solutions covering various phases of the development process, such as antibody development and optimization, druggability assessment, animal model evaluation, and process development.

Sino Biological provides comprehensive solutions for CAR-T cell therapy companies from CAR development, T cell activation, lentivirus packaging, CAR-T cell expansion to CAR-T cell quality control, fully supporting CAR-T research.

Sino Biological has developed a series of high-quality research reagents for dominant SARS-CoV-2 mutants, including recombinant antigens, detection antibodies, ELISA kits, pseudovirus, cDNAs, peptide pools, and receptor ACE2. These variant reagents have actively supported the basic research of SARS-CoV-2 and the development of vaccines, therapeutic antibodies, and diagnostic reagents.

Owing to the importance of in vitro screening and target validation during the early stages of antibody discovery, Sino Biological has established in vitro activity assay platforms for streamlining antibody drug development projects.